How Will the Addictions Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the addictions therapeutics market right now?
The market for addiction treatment therapies has experienced robust growth in the past few years. Its size is projected to increase from $7.05 billion in 2024 to $7.48 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 6.1%. The historically observed growth can be associated with the elevated usage of addictive elements like alcohol, tobacco, and drugs, growing recognition and ever-increasing instances of substance abuse disorders. Additionally, the legalization of marijuana in several jurisdictions and the rise in funding and support for drug rehabilitation initiatives have also contributed to the growth.
How fast Is the addictions therapeutics market expected to grow, and what’s its future value?
The market for addictions therapeutics is predicted to witness robust growth over the coming years, with an expected valuation of $9.62 billion in 2029 and an annual compound growth rate of 6.5%. The surge in growth during the forecast years can be credited to the increase in drug awareness campaigns, the introduction of synthetic drugs and novel psychoactive substances, lifestyle changes and stress factors, expansion of rehabilitation centres, and the incorporation of telehealth services in addiction treatment. The forecast period will also see predominant trends such as advancements in diagnostic technology, progress in neuroscience, collaborations and partnerships among pharmaceutical firms and other interested parties to address addiction problems, and the introduction of innovative drugs for addiction therapeutics.
Get your addictions therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report
What are the leading drivers of growth in the addictions therapeutics market?
The rise in alcohol consumption is anticipated to fuel the expansion of the addiction therapeutics market. Drinking of alcoholic beverages, which contain ethyl alcohol, constitutes alcohol consumption. Addiction therapeutics are utilized to manage alcohol-related addictions, induce a reduction in alcohol consumption by suppressing the gloomy effects of alcohol, balance the excitatory and inhibitory neurotransmitters glutamate and gamma-aminobutyric acid within an individual, which leads to lessened alcohol cravings, and help in alleviating symptoms like insomnia, anxiety, and restlessness due to alcohol withdrawal. For instance, a report by Statistics Canada revealed that the sales of alcohol beverages at retail spots and liquor authorities noted a 2.4% increase from the last year, totaling $26.1 billion for the fiscal year that ended on March 31, 2022. In the same duration, sales of wine noted a boost of 2.1%, amounting to $8.1 billion. Looking at the overall market composition, beer made up 34.9% of the total alcohol sales in 2021-2022, followed by wine (31.3%), spirits (25.8%), and ciders and coolers (8.0%). Thus, the uptick in alcohol consumption is contributing to the growth of the addiction therapeutics market.
What are the key segments defining the addictions therapeutics market?
The addictions therapeutics market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel
5) By Application: Public, Private, Government
Subsegments:
1) By Buprenorphine: Subutex, Suboxone
2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)
3) By Bupropion: Wellbutrin, Zyban
4) By Disulfiram: Antabuse
5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges
6) By Varenicline: Chantix (Champix)
7) By Other Drugs: Acamprosate, Topiramate, Gabapentin
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp
Who are the key players steering the development of the addictions therapeutics market?
Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.
What emerging trends are influencing the growth of the addictions therapeutics market?
Main players in the addiction therapeutics market, such as drug manufacturers for cocaine use disorders (CUD), are branching out to create novel products to expand customer reach, boost sales, and enhance income. These drugs are formulated to aide individuals battling with an addiction or reliance on cocaine. For example, in January 2023, Tempero Bio, a biopharmaceutical entity based in the U.S., received the green light from the U.S. Food and Drug Administration (FDA) for TMP-301. What set TMP-301 apart, a prospective candidate under Tempero Bio’s investigation, was its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). TMP-301, specifically designed for a significant role in managing cocaine use disorders (CUD), is noted for its efficiency, selectivity, and oral administration, all of which are directed toward effectively managing the excessive glutamate signaling linked to CUD.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12129
Which regions are most influential in expanding the addictions therapeutics market?
North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
Rituximab Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report
Acute Myeloid Leukemia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
